[go: up one dir, main page]

GB201612920D0 - Composition for the treatment of Duchenne Muscular Dystrophy - Google Patents

Composition for the treatment of Duchenne Muscular Dystrophy

Info

Publication number
GB201612920D0
GB201612920D0 GBGB1612920.7A GB201612920A GB201612920D0 GB 201612920 D0 GB201612920 D0 GB 201612920D0 GB 201612920 A GB201612920 A GB 201612920A GB 201612920 D0 GB201612920 D0 GB 201612920D0
Authority
GB
United Kingdom
Prior art keywords
treatment
composition
muscular dystrophy
duchenne muscular
duchenne
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1612920.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Summit (oxford) Ltd
Original Assignee
Summit (oxford) Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Summit (oxford) Ltd filed Critical Summit (oxford) Ltd
Priority to GBGB1612920.7A priority Critical patent/GB201612920D0/en
Publication of GB201612920D0 publication Critical patent/GB201612920D0/en
Priority to EP17720203.3A priority patent/EP3500245A1/en
Priority to MX2018012018A priority patent/MX2018012018A/en
Priority to CN201780033487.5A priority patent/CN109803641A/en
Priority to AU2017243198A priority patent/AU2017243198A1/en
Priority to JP2018551258A priority patent/JP2019510056A/en
Priority to KR1020187031329A priority patent/KR20190026647A/en
Priority to BR112018070076-2A priority patent/BR112018070076A2/en
Priority to PCT/GB2017/050884 priority patent/WO2017168151A1/en
Priority to IL262013A priority patent/IL262013A/en
Priority to US16/144,809 priority patent/US20200016076A1/en
Priority to PH12018502276A priority patent/PH12018502276A1/en
Ceased legal-status Critical Current

Links

GBGB1612920.7A 2016-03-30 2016-07-26 Composition for the treatment of Duchenne Muscular Dystrophy Ceased GB201612920D0 (en)

Priority Applications (12)

Application Number Priority Date Filing Date Title
GBGB1612920.7A GB201612920D0 (en) 2016-07-26 2016-07-26 Composition for the treatment of Duchenne Muscular Dystrophy
PCT/GB2017/050884 WO2017168151A1 (en) 2016-03-30 2017-03-29 Composition for the treatment of duchenne muscular dystrophy
AU2017243198A AU2017243198A1 (en) 2016-03-30 2017-03-29 Composition for the treatment of duchenne muscular dystrophy
MX2018012018A MX2018012018A (en) 2016-03-30 2017-03-29 Composition for the treatment of duchenne muscular dystrophy.
CN201780033487.5A CN109803641A (en) 2016-03-30 2017-03-29 For treating the composition of Du's Xing Shi muscular dystrophy
EP17720203.3A EP3500245A1 (en) 2016-03-30 2017-03-29 Composition for the treatment of duchenne muscular dystrophy
JP2018551258A JP2019510056A (en) 2016-03-30 2017-03-29 Composition for the treatment of Duchenne muscular dystrophy
KR1020187031329A KR20190026647A (en) 2016-03-30 2017-03-29 Composition for the treatment of duchlene muscular dystrophy
BR112018070076-2A BR112018070076A2 (en) 2016-03-30 2017-03-29 composition for the treatment of duchenne muscular dystrophy
IL262013A IL262013A (en) 2016-03-30 2018-09-27 Composition for the treatment of duchenne muscular dystrophy
US16/144,809 US20200016076A1 (en) 2016-03-30 2018-09-27 Composition for the treatment of duchenne muscular dystrophy
PH12018502276A PH12018502276A1 (en) 2016-03-30 2018-10-25 Composition for the treatment of duchenne muscular dystrophy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1612920.7A GB201612920D0 (en) 2016-07-26 2016-07-26 Composition for the treatment of Duchenne Muscular Dystrophy

Publications (1)

Publication Number Publication Date
GB201612920D0 true GB201612920D0 (en) 2016-09-07

Family

ID=56894525

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1612920.7A Ceased GB201612920D0 (en) 2016-03-30 2016-07-26 Composition for the treatment of Duchenne Muscular Dystrophy

Country Status (1)

Country Link
GB (1) GB201612920D0 (en)

Similar Documents

Publication Publication Date Title
IL290160A (en) Compositions and methods for treating duchenne muscular dystrophy and related disorders
HUS2100037I1 (en) Compounds for the treatment of spinal muscular atrophy
IL275482A (en) Esketamine for the treatment of depression
PT3261726T (en) Composition for the treatment of acne
IL272791A (en) Methods for treating muscular dystrophy
ZA201704957B (en) Composition for the treatment of hepatic veno-occlusive disease
EP3307891B8 (en) Combined therapy for duchenne muscular dystrophy
IL259178A (en) Methods of treating muscular dystrophy
PT3286317T (en) Dynamin 2 inhibitor for the treatment of duchenne's muscular dystrophy
ZA201601869B (en) Improved process for the preparation of apremilast
GB201516676D0 (en) Means for the treatment of HIV
IL253773B (en) Treatment of facioscapulohumeral dystrophy
IL252774A0 (en) Pharmaceutical composition for the treatment of mycosis
IL267059A (en) Composition for the treatment of osteoarthritis
IL262013A (en) Composition for the treatment of duchenne muscular dystrophy
IL255167A0 (en) Compositions for the treatment of cancer
GB201612920D0 (en) Composition for the treatment of Duchenne Muscular Dystrophy
GB201605380D0 (en) Composition for the treatment of duchenne muscular dystrophy
GB201605383D0 (en) Composition for the treatment of duchenne muscular dystrophy
PT3310711T (en) Process for the preparation of sodiuim cyanide
PL3164110T3 (en) Pharmaceutical compositions for the treatment of psoriasis
HK1259652A1 (en) Compositions and methods for treating duchenne muscular dystrophy and related disorders
GB201418513D0 (en) Compounds for the treatment of muscular dystrophy having improved bioavailability
HK40004668A (en) Crispr/cas-related methods and compositions for treating duchenne muscular dystrophy
PT3524255T (en) Composition for the treatment of acne

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)